A previous study on Middle East Respiratory Syndrome (MERS)-based vaccine has shown that membrane-anchored, prefusion-stabilized, full-length MERS spike antigen elicited more potent pseudovirus-neutralizing antibody responses than the soluble form, as mRNA immunogen28. This evidence concerns the gene CHMP5 and Middle East respiratory syndrome.